Henry A. Glick, PhD
 |
- Professor of Medicine, Division of General Internal Medicine
- Professor of Health Care Systems, Wharton School
- Director, Cost-Effectiveness Analysis, Leonard Davis Institute of Health Economics Center for Health Incentives and Behavioral Economics
- Senior Fellow, Leonard Davis Institute of Health Economics
- Associate Scholar, Center for Clinical Epidemiology and Biostatistics
|
Henry A. Glick, Ph.D. received an M.A. and Ph.D. in Public Policy Analysis from the University of Pennsylvania. He has more then 25 years of experience conducting economic assessments of medical therapies. He specializes in economic evaluations conducted as part of clinical trials. He also has extensive experience with decision analysis, preference assessment, analysis of observational data, and the evaluation of diagnostic tests.
Henry is co-chair of the Economics Committee for the "Action for Health in Diabetes (LookAHEAD) Study” a large randomized trial sponsored by the National Institute of Diabetes and Digestive and Kidney Disease and the head of the economics core of REVIVE-IT, an NHLBI trial evaluating left ventricular assist devices. He has also served on the Randomized Clinical Trial-Cost Effectiveness Analysis (RCT-CEA) Task Force and the Task Force on Good Research Practices
on Transferability of Economic Data in Health Technology
Assessment, which were chartered by the International Society of Pharmaceutical Outcomes Research (ISPOR) to develop guidance documents for good research practices for CEA analysis alongside clinical trials and for transfering the results of these studies.
He has co-taught two classes at the University of Pennsylvania since 1986: “Clinical Economics and Clinical Decision Making” as part of the Masters of Clinical Epidemiology program in the School of Medicine and “Cost Benefit and Cost Effectiveness Analysis in Healthcare” as part of the Ph.D. program in Wharton’s Health Care Systems Department. He regularly leads short courses in methods for economic assessments in clinical trials at meetings of several national and international societies. He has also been invited to present similar lectures at the Food and Drug Administration, Department of Veterans Affairs, and pharmaceutical companies.
Henry has published over 130 peer-reviewed articles, editorials, reviews, and book chapters and is the lead author of Economic Evaluation in Clinical Trials (Oxford: OUP, 2007). He has written extensively about methods for conducting economic assessments and estimated the value for the cost of therapies in areas such as heart failure, stroke, cancer, major infections, nutritional support, and weight loss. His work has appeared in journals such as Health Economics, Health Services Research, Medical Care, Medical Decision Making, Statistics in Medicine, Pediatrics, the Annals of Internal Medicine, JAMA, and NEJM. He also serves on the editorial board of the American Journal of Managed Care. |
